Seven weeks. 22 residents. Eight clinical findings.
Recorded observations from about seven weeks of live monitoring at one assisted living and memory care community, beginning around July 21, 2026. Each finding followed a reviewed change in that resident's own trend and a clinical evaluation.
Scope of this update
- Community
- One assisted living and memory care community, 86 residents total.
- Monitored sample
- 22 residents.
- Period
- About seven weeks of live monitoring, beginning around July 21, 2026.
- Monitoring volume
- About 35 resident-months of continuous overnight monitoring, described as 1,000+ resident-nights.
- Analysis volume
- About 1,100 readings analyzed per day across the pilot, 50,000+ analyzed to date.
Residents monitored
In one assisted living and memory care community of 86 residents. 86 is the community population, not the monitored sample.
Clinically confirmed findings
Each followed a reviewed change in that resident's own trend and a clinical evaluation.
UTIs confirmed
Confirmed by urinalysis or hospital diagnosis.
Treated in place
Managed in the resident's own bed under the treating provider's direction. One finding led to a provider-directed hospital transfer.
Resident-nights monitored
About 35 resident-months of continuous overnight monitoring.
Readings analyzed to date
About 1,100 analyzed readings per day across the pilot, not per resident. These are analyzed observations, not independent clinical cases.
Clinical findings and provider actions
Earlier detection, reported to providers
In the cases that had laboratory confirmation, changes were reported 1 to 7 days before that confirmation. Observed in cases with laboratory confirmation; not a guaranteed detection window.
A newly diagnosed arrhythmia, treatment changed
In one case, monitoring prompted a clinical evaluation that led the treating provider to diagnose atrial tachycardia and change treatment. The sensor did not diagnose the arrhythmia.
Monitoring prompted a check. The provider directed the next step.
In one pilot case, BPHM monitoring prompted a follow-up blood-pressure check. That check recorded a blood pressure of 204/104 mmHg. The treating provider directed a hospital transfer for evaluation. This was the one provider-directed transfer among the eight reported findings. The other seven were treated in place. The contactless sensor does not measure blood pressure.
Methodology and limitations
- How to read these numbers
- BPHM-reported observations from one pilot community, with no comparison group. These findings do not establish a hospitalization reduction rate or predict results in other settings.
- Continuous collection, daily review
- The sensor collects readings continuously. Our clinical team reviews each resident's trends daily against protocols signed by our Medical Director. Those are two different things.
- What the sensor does and does not do
- The sensor records resting heart rate, respiratory rate and movement patterns. It does not diagnose any condition. A change in trend prompts clinical review, and the treating provider decides on evaluation, testing and treatment.
- More detail
- Request the pilot methodology for details on scope, observation period and how outcomes are documented.
Want the pilot methodology?
Request the pilot methodology for details on scope, observation period and how outcomes are documented, and we will talk through what a pilot in your own community or agency would measure.
Schedule a Demo